awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42770955-68FFFBF7-03C2-4F4A-B461-800C660FF86F
Q42770955-68FFFBF7-03C2-4F4A-B461-800C660FF86F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-68FFFBF7-03C2-4F4A-B461-800C660FF86F
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.
P2860
Q42770955-68FFFBF7-03C2-4F4A-B461-800C660FF86F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-68FFFBF7-03C2-4F4A-B461-800C660FF86F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
830bab48ca3b76986406b17640a40b7d40afa6e9
P2860
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer.